Results 221 to 230 of about 53,685 (285)
Parkinson's disease in the United Arab Emirates (UAE): Emirates Neurology Society consensus guidelines. [PDF]
Front NeurolMittal SO +10 more
europepmc +1 more source
Diagnosing Dementias: Many Names, Many Faces
Journal of the American Geriatrics Society, EarlyView.
Michael Tran Duong
wiley +1 more source
Inhaled Levodopa for the Management of OFF Episodes in Patients with Parkinson's Disease: A Network Meta-analysis. [PDF]
Neurol TherMadani O +10 more
europepmc +1 more source
Serum aromatic l-amino acid decarboxylase activity as a biomarker for prodromal and manifest Parkinson's disease. [PDF]
EBioMedicineBeckers M +6 more
europepmc +1 more source
A novel approach to the management of levodopa-induced dyskinesia using deep transcranial magnetic stimulation: A case report. [PDF]
J Int Med ResSong IU, Kim B, Chung YA.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of Neurology, 2010
This paper reviews the clinically relevant determinants of levodopa peripheral pharmacokinetics and main observed changes in the levodopa concentration-effect relationship with Parkinson's disease (PD) progression. Available clinically practical strategies to optimise levodopa pharmacokinetics and pharmacodynamics are briefly discussed.
Manuela, Contin, Paolo, Martinelli
openaire +2 more sources
This paper reviews the clinically relevant determinants of levodopa peripheral pharmacokinetics and main observed changes in the levodopa concentration-effect relationship with Parkinson's disease (PD) progression. Available clinically practical strategies to optimise levodopa pharmacokinetics and pharmacodynamics are briefly discussed.
Manuela, Contin, Paolo, Martinelli
openaire +2 more sources
Clinical Pharmacology & Therapeutics, 1971
Based on the chemical constitution and metabolism of levodopa as well as on the effects of long‐term therapy in patients with parkinsonism, a hypothesis of pharmacologic activity which clearly differentiates it from conventional antiparkinsonian drugs is proposed.
G C, Cotzias +3 more
openaire +2 more sources
Based on the chemical constitution and metabolism of levodopa as well as on the effects of long‐term therapy in patients with parkinsonism, a hypothesis of pharmacologic activity which clearly differentiates it from conventional antiparkinsonian drugs is proposed.
G C, Cotzias +3 more
openaire +2 more sources
Neurology, 1974
We feel it prudent to sound a note of caution about the use of levodopa in patients with known melanomas or with pigmented lesions. Levodopa was administered to three of our patients with Parkinson9s disease and known melanomas or pigmented lesions.
A N, Lieberman, J L, Shupack
openaire +2 more sources
We feel it prudent to sound a note of caution about the use of levodopa in patients with known melanomas or with pigmented lesions. Levodopa was administered to three of our patients with Parkinson9s disease and known melanomas or pigmented lesions.
A N, Lieberman, J L, Shupack
openaire +2 more sources
JAMA: The Journal of the American Medical Association, 1972
To the Editor.— Entitled "Psychiatric Side Effects of Levodopa in Man,"1Frederick Goodwin's article inThe Journaldescribed visual hallucinations among the adverse side effects in Parkinsonian patients treated with levodopa. Prior to this, others2-6described psychosis as an occasional adverse side effect of therapy with levodopa.
openaire +2 more sources
To the Editor.— Entitled "Psychiatric Side Effects of Levodopa in Man,"1Frederick Goodwin's article inThe Journaldescribed visual hallucinations among the adverse side effects in Parkinsonian patients treated with levodopa. Prior to this, others2-6described psychosis as an occasional adverse side effect of therapy with levodopa.
openaire +2 more sources